Skip to main content
Renalytix Plc (RNLX)
NASDAQ: RNLX · IEX Real-Time Price · USD
0.700
-0.059 (-7.76%)
At close: May 3, 2024, 4:00 PM
0.707
+0.006 (0.91%)
Pre-market: May 6, 2024, 8:03 AM EDT

Renalytix Revenue

Renalytix had revenue of $2.41M in the twelve months ending December 31, 2023, down -36.65% year-over-year. Revenue in the quarter ending December 31, 2023 was $709.00K, a -40.52% decrease year-over-year. In the fiscal year ending June 30, 2023, Renalytix had annual revenue of $3.40M with 14.58% growth.

Revenue (ttm)
$2.41M
Revenue Growth
-36.65%
P/S Ratio
19.82
Revenue / Employee
$23,627
Employees
102
Market Cap
53.21M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20233.40M433.00K14.58%
Jun 30, 20222.97M1.48M99.20%
Jun 30, 20211.49M--
Jun 30, 20200--
Jun 30, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aadi Bioscience 24.35M
Ocuphire Pharma 19.05M
Enzo Biochem 12.81M
IceCure Medical 3.23M
Checkpoint Therapeutics 103.00K
Revenue Rankings

RNLX News

More News